Study Stopped
The principal investigator decided to stop the study.
Study On Discopathie With Modic 1
1 other identifier
observational
20
1 country
1
Brief Summary
The chronic lumbago can be associated with an active discopathie, objectified on the MRI by the presence of an inflammatory signal (Modic 1) or greasy (Modic 2) vertebral trays framing the pathological vertebral disk The treatment recommended by t consists in particular of a local infiltration of corticoids which the efficiency is variable according to the patients. The objective of this study is to estimate the efficiency of the local treatment and to highlight some of the factors associated to the advantage of the infiltration by corticoids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2017
CompletedFirst Submitted
Initial submission to the registry
October 2, 2017
CompletedFirst Posted
Study publicly available on registry
October 6, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedFebruary 4, 2019
March 1, 2018
1.4 years
October 2, 2017
February 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
pain VAS ( VISUAL ANALOGIC SCORE)
Day 1 - Day 30
Eligibility Criteria
patient hospitalized in GHPSJ for infiltration
You may qualify if:
- Patient admitted in Rhumatology service for intra-disc infiltration
- Chronic pain (\>3 monts)
- VAS \>3
- MRI stipulating MODIC 1
You may not qualify if:
- radiculalgy
- radicular VAS\< lumbar VAS
- pregnancy
- local infection
- corticoid allergy
- previous rachial surgery
- previous spondylodiscite
- psychiatric disorder
- MRI contraindication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
COHEN SOLAL P Julien, MD
Fondation Hôpital Saint-Joseph
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2017
First Posted
October 6, 2017
Study Start
April 18, 2016
Primary Completion
September 25, 2017
Study Completion
December 31, 2018
Last Updated
February 4, 2019
Record last verified: 2018-03